Drugs / GSK Malaria vaccine 257049
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00443131 | Mar → Jul 2007 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK Malaria vaccine 257049 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00443131 ↗ |
| Modality | Vaccine | “two experimental malaria vaccines” NCT00443131 ↗ |
| Route | Intramuscular | “Three-dose vaccination by slow intramuscular injection.” NCT00443131 ↗ |